Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Friday, July 22, 2016
Tricare drops UnitedHealthcare from new contracts worth $58 billion
The U.S. Department of Defense has awarded multiyear contracts worth $58 billion to Humana and Centene Corp. to manage Tricare, surprisingly booting incumbent health insurer UnitedHealthcare in the process. READ MORE
FDA rejects Sandoz's Neulasta copy, giving Amgen a break from the biosim onslaught
Tuesday, July 19, 2016
Amgen’s aging superstars have been under assault lately by Novartis’ Sandoz unit and its biosimilars ambitions. But the Big Biotech scored a break at the hands of regulators: The FDA rebuffed Sandoz's biosim version of Amgen's big-selling Neulasta, Novartis disclosed Tuesday.
07/22/2016 01:04 PM EDT
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Xcelerated Weight Loss Turbo Charge, a product promoted and sold for weight loss on various websites, includingwww.xceleratedweightloss.com, and possibly in some retail stores.
Subscribe to:
Posts (Atom)